Authors:
WERMUTH L
SORENSEN PS
TIMM S
CHRISTENSEN B
UTZON NP
BOAS J
DUPONT E
HANSEN E
MAGNUSSEN I
MIKKELSEN B
WORMPETERSEN J
LAURITZEN L
BAYER L
BECH P
Citation: L. Wermuth et al., DEPRESSION IN IDIOPATHIC PARKINSONS-DISEASE TREATED WITH CITALOPRAM -A PLACEBO-CONTROLLED TRIAL, Nordic journal of psychiatry, 52(2), 1998, pp. 163-169
Authors:
RINNE UK
LARSEN JP
SIDEN A
WORMPETERSEN J
Citation: Uk. Rinne et al., ENTACAPONE ENHANCES THE RESPONSE TO LEVODOPA IN PARKINSONIAN-PATIENTSWITH MOTOR FLUCTUATIONS, Neurology, 51(5), 1998, pp. 1309-1314
Authors:
LARSEN JP
BOAS J
AASLY J
BOESEN F
BOISEN E
BORGMANN R
DUPONT E
ERDAL JE
GILHUS NE
HEINONEN E
HUNSTAD N
KILKKU O
MAI J
MELLGREN SI
MIKKELSEN B
NESSLER E
SELSETH B
VILMING S
WERMUTH L
WORMPETERSEN J
OKSETER K
Citation: Jp. Larsen et al., THE EFFECTS OF EARLY SELEGILINE THERAPY ON LONG-TERM LEVODOPA TREATMENT AND PARKINSONIAN DISABILITY - AN INTERIM ANALYSIS OF A NORWEGIAN-DANISH 5-YEAR STUDY, Movement disorders, 12(2), 1997, pp. 175-182
Authors:
BOAS J
WORMPETERSEN J
DUPONT E
MIKKELSEN B
WERMUTH L
Citation: J. Boas et al., THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE IN AN OPEN-LABEL, CROSSOVER STUDY, European journal of neurology, 3(1), 1996, pp. 44-49
Authors:
DUPONT E
BOAS J
MIKKELSEN B
WERMUTH L
WORMPETERSEN J
Citation: E. Dupont et al., THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE, European journal of neurology, 3, 1996, pp. 9-12
Authors:
DUPONT E
ANDERSEN A
BOAS J
BOISEN E
BORGMANN R
HELGETVEIT AC
KJAER MO
KRISTENSEN TN
MIKKELSEN B
PAKKENBERG H
PRESTHUS J
STIEN R
WORMPETERSEN J
BUCH D
Citation: E. Dupont et al., SUSTAINED-RELEASE MADOPAR HBS(R) COMPARED WITH STANDARD MADOPAR(R) INTHE LONG-TERM TREATMENT OF DE-NOVO PARKINSONIAN-PATIENTS, Acta neurologica Scandinavica, 93(1), 1996, pp. 14-20